32 results on '"Pfister Marc"'
Search Results
2. Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases
3. Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire
4. Low-dimensional neural ODEs and their application in pharmacokinetics
5. Pharmacokinetics of oral spironolactone in infants up to 2 years of age
6. Computing optimal drug dosing with OptiDose: implementation in NONMEM
7. Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations
8. Tapering of biological treatment in autoinflammatory diseases: a scoping review
9. Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model
10. Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen
11. Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
12. Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age
13. The rhythm of a preterm neonate’s life: ultradian oscillations of heart rate, body temperature and sleep cycles
14. OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
15. Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
16. Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
17. Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
18. Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
19. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women
20. Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study
21. Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning
22. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
23. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency
24. Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop
25. Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
26. Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy
27. Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia
28. Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women
29. Modeling and simulation of adherence: Approaches and applications in therapeutics
30. The International Society of Pharmacometrics
31. The American Conference on Pharmacometrics 2013
32. Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.